KorrekturKohortenstudieOpen Access · CC BY-NC 4.0
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study
BMJ · 28.04.2025 · 389 · r845
DOI: 10.1136/bmj.r845 ↗Kurz gefasst
Korrektur in der Zeitschrift BMJ, online erschienen am 28.04.2025. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2025). Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study. BMJ, 389, r845. https://doi.org/10.1136/bmj.r845
Vancouver
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study. BMJ. 2025;389:r845. doi:10.1136/bmj.r845
BibTeX
@article{euvimed2025,
title = {Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study},
journal = {BMJ},
year = {2025},
volume = {389},
pages = {r845},
doi = {10.1136/bmj.r845}
}
EUVIMED